02.03.2013 Views

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Transgenic Models 187<br />

period of incubation. AD is characterized by the extracellular accumulation of<br />

polymerized tau protein. β-Amyloid is cleaved from amyloid precursor protein<br />

(ADP), the cleavage being performed by three secretases: -α, -β, <strong>and</strong> -γ (126).<br />

Transgenic mice, in which the ADP gene had been knocked out, kept their sensitivity<br />

to the disease (127) because of the presence of another gene called<br />

ADP-like gene. The knockout of the gene is lethal. Transgenic mice with<br />

knocked-out ApoE <strong>and</strong> IL1 genes are less sensitive to the disease, indicating<br />

that these two genes contribute to AD development.<br />

Different models have been obtained. Some of the models overexpress normal<br />

APD <strong>and</strong> prenisilin genes, whereas other models express mutated forms of<br />

the genes. None of these models reflect all the aspects of AD. Fewer neurons in<br />

generals are destroyed in the models than in patients. Correlation between<br />

behavioral disorders <strong>and</strong> accumulation of β-amyloid is not always strict. Yet,<br />

the models show a similar disease pattern, <strong>and</strong> they may therefore help to identify<br />

active molecules <strong>and</strong> to design analogs capable of reaching the brain (128).<br />

4.6. Models for Degenerative Diseases<br />

Degenerative diseases generally have slow development, <strong>and</strong> transgenic<br />

models may be helpful to decipher their mechanisms, not only for Alzheimer’s<br />

disease but also for prion diseases <strong>and</strong> other pathologies. Prion diseases would<br />

be much less well understood without the contribution of transgenic mice<br />

(129,130). Creutzfeldt–Jakob <strong>and</strong> related diseases are typically pathologies,<br />

which incubate for very long periods <strong>and</strong> require the cooperation of several cell<br />

types, especially when infection occurs by the oral route. It was essential to<br />

show that the PrP–/– mice were insensitive to any prion infection, which then<br />

demonstrated that the PrP gene has a major role in prion diseases.<br />

Transgenic mice overexpressing the PrP genes from different species<br />

become more sensitive to the prion disease of the same species. This phenomenon<br />

is amplified when the endogenous mouse PrP gene is knocked out. For<br />

example, PrP–/– mice expressing the bovine PrP gene are sensitive to bovine<br />

spongiform encephalopathy (131). PrP–/– mice expressing the hamster PrP<br />

gene specifically in astrocytes are sensitive to hamster scrapie (132). Transgenic<br />

mice also revealed that some epitopes of the PrP protein are essential for the<br />

transmission of the disease (133), that some PrP alleles are more favorable for<br />

injection than others, <strong>and</strong> that genetic environmental factors modify the incubation<br />

period of bovine spongiform encephalopathy (134).<br />

The prion disease manifests more rapidly when the PrP gene of the mouse<br />

<strong>and</strong> the cell extract used for infection come from more closely related species.<br />

It was also surprising to observe that the cell extracts become increasingly<br />

infectious after repeated passages to animals. This adaptation has not yet been

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!